Recent clinical studies surrounding Retatrutide , specifically the 120mg formulation referred to as ZPHC, suggest a impressive effect on weight decrease and related health conditions . Researchers posit that this innovative agonist , targeting both GLP-1 and GIP pathways , could provide a major b